Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Buy
58
MMSI Quote, Financials, Valuation and Earnings
Last price:
$87.63
Seasonality move
:
1.25%
Day range:
$86.76 - $88.59
52-week range:
$78.12 - $111.45
Dividend yield:
0%
P/E ratio:
44.85x
P/S ratio:
3.60x
P/B ratio:
3.40x
Volume:
605.1K
Avg. volume:
680.5K
1-year change:
-10.22%
Market cap:
$5.2B
Revenue:
$1.4B
EPS (TTM):
$1.95
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
MMSI
Merit Medical Systems, Inc.
|
$371.7M | $0.83 | 9.51% | 106.1% | $103.60 |
|
BSX
Boston Scientific Corp.
|
$5B | $0.71 | 15.97% | 105.65% | $125.86 |
|
IART
Integra LifeSciences Holdings Corp.
|
$414.3M | $0.43 | -2.94% | 217.65% | $15.50 |
|
MASI
Masimo Corp.
|
$366.9M | $1.20 | -32.15% | 565.51% | $183.75 |
|
PODD
Insulet Corp.
|
$679M | $1.15 | 28.59% | 5.4% | $377.72 |
|
TNDM
Tandem Diabetes Care, Inc.
|
$235.8M | -$0.34 | -2.02% | -4.07% | $24.81 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
MMSI
Merit Medical Systems, Inc.
|
$87.63 | $103.60 | $5.2B | 44.85x | $0.00 | 0% | 3.60x |
|
BSX
Boston Scientific Corp.
|
$96.08 | $125.86 | $142.4B | 51.39x | $0.00 | 0% | 7.41x |
|
IART
Integra LifeSciences Holdings Corp.
|
$12.59 | $15.50 | $980.7M | 70.14x | $0.00 | 0% | 0.59x |
|
MASI
Masimo Corp.
|
$133.87 | $183.75 | $7.2B | 116.80x | $0.00 | 0% | 4.23x |
|
PODD
Insulet Corp.
|
$285.50 | $377.72 | $20.1B | 82.84x | $0.00 | 0% | 8.19x |
|
TNDM
Tandem Diabetes Care, Inc.
|
$22.62 | $24.81 | $1.5B | -- | $0.00 | 0% | 1.50x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
MMSI
Merit Medical Systems, Inc.
|
34.93% | 0.293 | 16.64% | 2.67x |
|
BSX
Boston Scientific Corp.
|
33.99% | 0.345 | 8.31% | 0.81x |
|
IART
Integra LifeSciences Holdings Corp.
|
65.91% | 0.130 | 179.84% | 1.47x |
|
MASI
Masimo Corp.
|
41.99% | 0.805 | 7.4% | 1.68x |
|
PODD
Insulet Corp.
|
42.7% | 1.380 | 4.75% | 1.89x |
|
TNDM
Tandem Diabetes Care, Inc.
|
77.16% | 1.243 | 54.61% | 1.79x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
MMSI
Merit Medical Systems, Inc.
|
$186.5M | $42.8M | 5.28% | 8.28% | 11.13% | $51.5M |
|
BSX
Boston Scientific Corp.
|
$3.3B | $1B | 8.19% | 12.46% | 20.55% | $1.2B |
|
IART
Integra LifeSciences Holdings Corp.
|
$226.1M | $25.9M | -14.85% | -37.15% | 6.43% | $25.8M |
|
MASI
Masimo Corp.
|
$230.6M | $83.7M | -11.41% | -19.18% | 22.53% | $49.7M |
|
PODD
Insulet Corp.
|
$513.5M | $117.7M | 9.14% | 18.92% | 16.66% | $94.6M |
|
TNDM
Tandem Diabetes Care, Inc.
|
$134.3M | -$20.1M | -31.16% | -110.24% | -8.05% | $4.2M |
Merit Medical Systems, Inc. vs. Competitors
-
Which has Higher Returns MMSI or BSX?
Boston Scientific Corp. has a net margin of 7.22% compared to Merit Medical Systems, Inc.'s net margin of 14.91%. Merit Medical Systems, Inc.'s return on equity of 8.28% beat Boston Scientific Corp.'s return on equity of 12.46%.
Company Gross Margin Earnings Per Share Invested Capital MMSIMerit Medical Systems, Inc.48.54% $0.46 $2.4B BSXBoston Scientific Corp.65.31% $0.50 $35.7B -
What do Analysts Say About MMSI or BSX?
Merit Medical Systems, Inc. has a consensus price target of $103.60, signalling upside risk potential of 18.22%. On the other hand Boston Scientific Corp. has an analysts' consensus of $125.86 which suggests that it could grow by 30.52%. Given that Boston Scientific Corp. has higher upside potential than Merit Medical Systems, Inc., analysts believe Boston Scientific Corp. is more attractive than Merit Medical Systems, Inc..
Company Buy Ratings Hold Ratings Sell Ratings MMSIMerit Medical Systems, Inc.4 1 0 BSXBoston Scientific Corp.25 2 0 -
Is MMSI or BSX More Risky?
Merit Medical Systems, Inc. has a beta of 0.615, which suggesting that the stock is 38.504% less volatile than S&P 500. In comparison Boston Scientific Corp. has a beta of 0.673, suggesting its less volatile than the S&P 500 by 32.691%.
-
Which is a Better Dividend Stock MMSI or BSX?
Merit Medical Systems, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Boston Scientific Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Merit Medical Systems, Inc. pays -- of its earnings as a dividend. Boston Scientific Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MMSI or BSX?
Merit Medical Systems, Inc. quarterly revenues are $384.3M, which are smaller than Boston Scientific Corp. quarterly revenues of $5.1B. Merit Medical Systems, Inc.'s net income of $27.8M is lower than Boston Scientific Corp.'s net income of $755M. Notably, Merit Medical Systems, Inc.'s price-to-earnings ratio is 44.85x while Boston Scientific Corp.'s PE ratio is 51.39x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Merit Medical Systems, Inc. is 3.60x versus 7.41x for Boston Scientific Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MMSIMerit Medical Systems, Inc.3.60x 44.85x $384.3M $27.8M BSXBoston Scientific Corp.7.41x 51.39x $5.1B $755M
-
Which has Higher Returns MMSI or IART?
Integra LifeSciences Holdings Corp. has a net margin of 7.22% compared to Merit Medical Systems, Inc.'s net margin of -1.34%. Merit Medical Systems, Inc.'s return on equity of 8.28% beat Integra LifeSciences Holdings Corp.'s return on equity of -37.15%.
Company Gross Margin Earnings Per Share Invested Capital MMSIMerit Medical Systems, Inc.48.54% $0.46 $2.4B IARTIntegra LifeSciences Holdings Corp.56.24% -$0.07 $3B -
What do Analysts Say About MMSI or IART?
Merit Medical Systems, Inc. has a consensus price target of $103.60, signalling upside risk potential of 18.22%. On the other hand Integra LifeSciences Holdings Corp. has an analysts' consensus of $15.50 which suggests that it could grow by 23.11%. Given that Integra LifeSciences Holdings Corp. has higher upside potential than Merit Medical Systems, Inc., analysts believe Integra LifeSciences Holdings Corp. is more attractive than Merit Medical Systems, Inc..
Company Buy Ratings Hold Ratings Sell Ratings MMSIMerit Medical Systems, Inc.4 1 0 IARTIntegra LifeSciences Holdings Corp.2 4 2 -
Is MMSI or IART More Risky?
Merit Medical Systems, Inc. has a beta of 0.615, which suggesting that the stock is 38.504% less volatile than S&P 500. In comparison Integra LifeSciences Holdings Corp. has a beta of 1.064, suggesting its more volatile than the S&P 500 by 6.408%.
-
Which is a Better Dividend Stock MMSI or IART?
Merit Medical Systems, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Integra LifeSciences Holdings Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Merit Medical Systems, Inc. pays -- of its earnings as a dividend. Integra LifeSciences Holdings Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MMSI or IART?
Merit Medical Systems, Inc. quarterly revenues are $384.3M, which are smaller than Integra LifeSciences Holdings Corp. quarterly revenues of $402.1M. Merit Medical Systems, Inc.'s net income of $27.8M is higher than Integra LifeSciences Holdings Corp.'s net income of -$5.4M. Notably, Merit Medical Systems, Inc.'s price-to-earnings ratio is 44.85x while Integra LifeSciences Holdings Corp.'s PE ratio is 70.14x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Merit Medical Systems, Inc. is 3.60x versus 0.59x for Integra LifeSciences Holdings Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MMSIMerit Medical Systems, Inc.3.60x 44.85x $384.3M $27.8M IARTIntegra LifeSciences Holdings Corp.0.59x 70.14x $402.1M -$5.4M
-
Which has Higher Returns MMSI or MASI?
Masimo Corp. has a net margin of 7.22% compared to Merit Medical Systems, Inc.'s net margin of 14.46%. Merit Medical Systems, Inc.'s return on equity of 8.28% beat Masimo Corp.'s return on equity of -19.18%.
Company Gross Margin Earnings Per Share Invested Capital MMSIMerit Medical Systems, Inc.48.54% $0.46 $2.4B MASIMasimo Corp.62.07% -$1.86 $1.4B -
What do Analysts Say About MMSI or MASI?
Merit Medical Systems, Inc. has a consensus price target of $103.60, signalling upside risk potential of 18.22%. On the other hand Masimo Corp. has an analysts' consensus of $183.75 which suggests that it could grow by 37.26%. Given that Masimo Corp. has higher upside potential than Merit Medical Systems, Inc., analysts believe Masimo Corp. is more attractive than Merit Medical Systems, Inc..
Company Buy Ratings Hold Ratings Sell Ratings MMSIMerit Medical Systems, Inc.4 1 0 MASIMasimo Corp.4 3 0 -
Is MMSI or MASI More Risky?
Merit Medical Systems, Inc. has a beta of 0.615, which suggesting that the stock is 38.504% less volatile than S&P 500. In comparison Masimo Corp. has a beta of 1.262, suggesting its more volatile than the S&P 500 by 26.208%.
-
Which is a Better Dividend Stock MMSI or MASI?
Merit Medical Systems, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Masimo Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Merit Medical Systems, Inc. pays -- of its earnings as a dividend. Masimo Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MMSI or MASI?
Merit Medical Systems, Inc. quarterly revenues are $384.3M, which are larger than Masimo Corp. quarterly revenues of $371.5M. Merit Medical Systems, Inc.'s net income of $27.8M is lower than Masimo Corp.'s net income of $53.7M. Notably, Merit Medical Systems, Inc.'s price-to-earnings ratio is 44.85x while Masimo Corp.'s PE ratio is 116.80x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Merit Medical Systems, Inc. is 3.60x versus 4.23x for Masimo Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MMSIMerit Medical Systems, Inc.3.60x 44.85x $384.3M $27.8M MASIMasimo Corp.4.23x 116.80x $371.5M $53.7M
-
Which has Higher Returns MMSI or PODD?
Insulet Corp. has a net margin of 7.22% compared to Merit Medical Systems, Inc.'s net margin of 12.4%. Merit Medical Systems, Inc.'s return on equity of 8.28% beat Insulet Corp.'s return on equity of 18.92%.
Company Gross Margin Earnings Per Share Invested Capital MMSIMerit Medical Systems, Inc.48.54% $0.46 $2.4B PODDInsulet Corp.72.7% $1.24 $2.4B -
What do Analysts Say About MMSI or PODD?
Merit Medical Systems, Inc. has a consensus price target of $103.60, signalling upside risk potential of 18.22%. On the other hand Insulet Corp. has an analysts' consensus of $377.72 which suggests that it could grow by 32.3%. Given that Insulet Corp. has higher upside potential than Merit Medical Systems, Inc., analysts believe Insulet Corp. is more attractive than Merit Medical Systems, Inc..
Company Buy Ratings Hold Ratings Sell Ratings MMSIMerit Medical Systems, Inc.4 1 0 PODDInsulet Corp.19 2 0 -
Is MMSI or PODD More Risky?
Merit Medical Systems, Inc. has a beta of 0.615, which suggesting that the stock is 38.504% less volatile than S&P 500. In comparison Insulet Corp. has a beta of 1.374, suggesting its more volatile than the S&P 500 by 37.428%.
-
Which is a Better Dividend Stock MMSI or PODD?
Merit Medical Systems, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Insulet Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Merit Medical Systems, Inc. pays -- of its earnings as a dividend. Insulet Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MMSI or PODD?
Merit Medical Systems, Inc. quarterly revenues are $384.3M, which are smaller than Insulet Corp. quarterly revenues of $706.3M. Merit Medical Systems, Inc.'s net income of $27.8M is lower than Insulet Corp.'s net income of $87.6M. Notably, Merit Medical Systems, Inc.'s price-to-earnings ratio is 44.85x while Insulet Corp.'s PE ratio is 82.84x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Merit Medical Systems, Inc. is 3.60x versus 8.19x for Insulet Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MMSIMerit Medical Systems, Inc.3.60x 44.85x $384.3M $27.8M PODDInsulet Corp.8.19x 82.84x $706.3M $87.6M
-
Which has Higher Returns MMSI or TNDM?
Tandem Diabetes Care, Inc. has a net margin of 7.22% compared to Merit Medical Systems, Inc.'s net margin of -8.49%. Merit Medical Systems, Inc.'s return on equity of 8.28% beat Tandem Diabetes Care, Inc.'s return on equity of -110.24%.
Company Gross Margin Earnings Per Share Invested Capital MMSIMerit Medical Systems, Inc.48.54% $0.46 $2.4B TNDMTandem Diabetes Care, Inc.53.88% -$0.31 $582.2M -
What do Analysts Say About MMSI or TNDM?
Merit Medical Systems, Inc. has a consensus price target of $103.60, signalling upside risk potential of 18.22%. On the other hand Tandem Diabetes Care, Inc. has an analysts' consensus of $24.81 which suggests that it could grow by 9.68%. Given that Merit Medical Systems, Inc. has higher upside potential than Tandem Diabetes Care, Inc., analysts believe Merit Medical Systems, Inc. is more attractive than Tandem Diabetes Care, Inc..
Company Buy Ratings Hold Ratings Sell Ratings MMSIMerit Medical Systems, Inc.4 1 0 TNDMTandem Diabetes Care, Inc.7 13 0 -
Is MMSI or TNDM More Risky?
Merit Medical Systems, Inc. has a beta of 0.615, which suggesting that the stock is 38.504% less volatile than S&P 500. In comparison Tandem Diabetes Care, Inc. has a beta of 1.685, suggesting its more volatile than the S&P 500 by 68.536%.
-
Which is a Better Dividend Stock MMSI or TNDM?
Merit Medical Systems, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Tandem Diabetes Care, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Merit Medical Systems, Inc. pays -- of its earnings as a dividend. Tandem Diabetes Care, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MMSI or TNDM?
Merit Medical Systems, Inc. quarterly revenues are $384.3M, which are larger than Tandem Diabetes Care, Inc. quarterly revenues of $249.3M. Merit Medical Systems, Inc.'s net income of $27.8M is higher than Tandem Diabetes Care, Inc.'s net income of -$21.2M. Notably, Merit Medical Systems, Inc.'s price-to-earnings ratio is 44.85x while Tandem Diabetes Care, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Merit Medical Systems, Inc. is 3.60x versus 1.50x for Tandem Diabetes Care, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MMSIMerit Medical Systems, Inc.3.60x 44.85x $384.3M $27.8M TNDMTandem Diabetes Care, Inc.1.50x -- $249.3M -$21.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 24
Applied Optoelectronics, Inc. [AAOI] is up 3.24% over the past day.
Buy
85
HUT alert for Dec 24
Hut 8 Corp. [HUT] is up 1.39% over the past day.
Buy
63
GPCR alert for Dec 24
Structure Therapeutics, Inc. [GPCR] is down 2.1% over the past day.
